Skip to main content
AAN.com

Abstract

Background and Objectives

Poor oral health is a modifiable risk factor that is associated with clinically observed cardiovascular disease. However, the relationship between oral and brain health is not well understood. We tested the hypothesis that poor oral health is associated with worse neuroimaging brain health profiles in middle-aged persons without stroke or dementia.

Methods

We performed a 2-stage cross-sectional neuroimaging study using UK Biobank data. First, we tested for association between self-reported poor oral health and MRI neuroimaging markers of brain health. Second, we used Mendelian randomization (MR) analyses to test for association between genetically determined poor oral health and the same neuroimaging markers. Poor oral health was defined as the presence of dentures or loose teeth. As instruments for the MR analysis, we used 116 independent DNA sequence variants linked to increased composite risk of dentures or teeth that are decayed, missing, or filled. Neuroimaging markers of brain health included white matter hyperintensity (WMH) volume and aggregate measures of fractional anisotropy (FA) and mean diffusivity (MD), 2 metrics indicative of white matter tract disintegrity obtained through diffusion tensor imaging across 48 brain regions.

Results

We included 40,175 persons (mean age 55 years, female sex 53%) enrolled from 2006 to 2010, who underwent a dedicated research brain MRI between 2014 and 2016. Among participants, 5,470 (14%) had poor oral health. Poor oral health was associated with a 9% increase in WMH volume (β = 0.09, SD = 0.014, p < 0.001), 10% change in aggregate FA score (β = 0.10, SD = 0.013, p < 0.001), and 5% change in aggregate MD score (β = 0.05, SD = 0.013, p < 0.001). Genetically determined poor oral health was associated with a 30% increase in WMH volume (β = 0.30, SD = 0.06, p < 0.001), 43% change in aggregate FA score (β = 0.43, SD = 0.06, p < 0.001), and 10% change in aggregate MD score (β = 0.10, SD = 0.03, p < 0.01).

Discussion

Among middle age Britons without stroke or dementia, poor oral health was associated with worse neuroimaging brain health profiles. Genetic analyses confirmed these associations, supporting a potentially causal association. Because the neuroimaging markers evaluated in this study precede and are established risk factors of stroke and dementia, our results suggest that oral health, an easily modifiable process, may be a promising target for very early interventions focused on improving brain health.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (supplementary_data.pdf)

References

1.
Carrizales-Sepúlveda EF, Ordaz-Farías A, Vera-Pineda R, Flores-Ramírez R. Periodontal disease, systemic inflammation and the risk of cardiovascular disease. Heart Lung Circ. 2018;27(11):1327-1334.
2.
Zhou M, Dong J, Zha L, Liao Y. Causal association between periodontal diseases and cardiovascular diseases. Genes. 2021;13(1):13.
3.
Fagundes NCF, Almeida APCPSC, Vilhena KFB, Magno MB, Maia LC, Lima RR. Periodontitis as a risk factor for stroke: a systematic review and meta-analysis. Vasc Health Risk Manag. 2019;15:519-532.
4.
Lockhart PB, Bolger AF, Papapanou PN, et al. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association? Circulation. 2012;125(20):2520-2544.
5.
Fagundes NCF, Couto RSD, Brandão APT, et al. Association between tooth loss and stroke: a systematic review. J Stroke Cerebrovasc Dis. 2020;29(8):104873.
6.
Asher S, Stephen R, Mäntylä P, Suominen AL, Solomon A. Periodontal health, cognitive decline, and dementia: a systematic review and meta-analysis of longitudinal studies. J Am Geriatr Soc. 2022;70(9):2695-2709.
7.
Guo H, Chang S, Pi X, et al. The effect of periodontitis on dementia and cognitive impairment: a meta-analysis. Int J Environ Res Public Health. 2021;18(13):6823.
8.
Fang WL, Jiang MJ, Gu BB, et al. Tooth loss as a risk factor for dementia: systematic review and meta-analysis of 21 observational studies. BMC Psychiatry. 2018;18(1):345.
9.
Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341:c3666.
10.
Tuladhar AM, Reid AT, Shumskaya E, et al. Relationship between white matter hyperintensities, cortical thickness, and cognition. Stroke. 2015;46(2):425-432.
11.
Xing Y, Yang J, Zhou A, et al. White matter fractional anisotropy is a superior predictor for cognitive impairment than brain volumes in older adults with confluent white matter hyperintensities. Front Psychiatry. 2021;12:633811.
12.
Shafer AT, Williams OA, Perez E, et al. Accelerated decline in white matter microstructure in subsequently impaired older adults and its relationship with cognitive decline. Brain Commun. 2022;4(2):fcac051.
13.
Burgess S, Davey Smith G, Davies NM, et al. Guidelines for performing Mendelian randomization investigations. Wellcome Open Res. 2020;4:186.
14.
Davies NM, Holmes MV, Smith GD. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601.
16.
Adult Oral Health | Basics | Division of Oral Health | CDC. Published March 15, 2023. Accessed May 5, 2023. cdc.gov/oralhealth/basics/adult-oral-health/index.html.
17.
Lancet T. Oral health: prevention is key. Lancet. 2009;373(9657):1.
18.
Miller KL, Alfaro-Almagro F, Bangerter NK, et al. Multimodal population brain imaging in the UK Biobank prospective epidemiological study. Nat Neurosci. 2016;19(11):1523-1536.
19.
Shungin D, Haworth S, Divaris K, et al. Genome-wide analysis of dental caries and periodontitis combining clinical and self-reported data. Nat Commun. 2019;10(1):2773.
20.
Jenkinson M, Beckmann CF, Behrens TEJ, Woolrich MW, Smith SM. FSL. Neuroimage. 2012;62(2):782-790.
21.
Griffanti L, Zamboni G, Khan A, et al. BIANCA (Brain Intensity AbNormality Classification Algorithm): a new tool for automated segmentation of white matter hyperintensities. Neuroimage. 2016;141:191-205.
22.
Gheorghe DA, Li C, Gallacher J, Bauermeister S. Associations of perceived adverse lifetime experiences with brain structure in UK Biobank participants. J Child Psychol Psychiatry. 2021;62(7):822-830.
23.
Cox SR, Ritchie SJ, Tucker-Drob EM, et al. Ageing and brain white matter structure in 3,513 UK Biobank participants. Nat Commun. 2016;7(1):13629.
24.
Sudlow C, Gallacher J, Allen N, et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779.
25.
Bycroft C, Freeman C, Petkova D, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562(7726):203-209.
26.
Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009;5(6):e1000529.
27.
McCarthy S, Das S, Kretzschmar W, et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet. 2016;48(10):1279-1283.
28.
Huang J, Howie B, McCarthy S, et al. Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel. Nat Commun. 2015;6(1):8111.
29.
Auton A, Abecasis GR, Altshuler DM, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68-74.
30.
Sanderson E, Glymour MM, Holmes MV. Mendelian randomization. Nat Rev Methods Primer. 2022;2(1):1-21.
31.
Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304-314.
32.
Burgess S, Foley CN, Allara E, Staley JR, Howson JMM. A robust and efficient method for Mendelian randomization with hundreds of genetic variants. Nat Commun. 2020;11(1):376.
33.
Broadbent JR, Foley CN, Grant AJ, Mason AM, Staley JR, Burgess S. MendelianRandomization v0.5.0: updates to an R package for performing Mendelian randomization analyses using summarized data. Wellcome Open Res. 2020;5:252.
34.
Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693-698.
35.
UKBiobank. UK Biobank research ethics approval. Updated December 3, 2021. ukbiobank.ac.uk/learn-more-about-uk-biobank/about-us/ethics
36.
Sekula P, Del Greco MF, Pattaro C, Köttgen A. Mendelian Randomization as an approach to assess causality using observational data. J Am Soc Nephrol. 2016;27(11):3253-3265.
37.
Wang X, Hu J, Jiang Q. Tooth loss-associated mechanisms that negatively affect cognitive function: a systematic review of animal experiments based on occlusal support loss and cognitive impairment. Front Neurosci. 2022;16:811335.
38.
Nangle MR, Riches J, Grainger SA, Manchery N, Sachdev PS, Henry JD. Oral health and cognitive function in older adults: a systematic review. Gerontology. 2019;65(6):659-672.
39.
Schwahn C, Frenzel S, Holtfreter B, et al. Effect of periodontal treatment on preclinical Alzheimer's disease: results of a trial emulation approach. Alzheimers Dement. 2022;18(1):127-141.
40.
Sheehan NA, Didelez V. Epidemiology, genetic epidemiology and Mendelian randomisation: more need than ever to attend to detail. Hum Genet. 2020;139(1):121-136.
41.
King EA, Davis JW, Degner JF. Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. PLoS Genet. 2019;15(12):e1008489.
42.
Campos MS, Marchini L, Bernardes LAS, Paulino LC, Nobrega FG. Biofilm microbial communities of denture stomatitis. Oral Microbiol Immunol. 2008;23(5):419-424.
43.
O'Donovan A, Bahorik A, Sidney S, Launer LJ, Yaffe K. Relationships of inflammation trajectories with white matter volume and integrity in midlife. Brain Behav Immun. 2021;91:81-88.
44.
Boots EA, Castellanos KJ, Zhan L, et al. Inflammation, cognition, and white matter in older adults: an examination by race. Front Aging Neurosci. 2020;12:553998.
45.
De Marchi RJ, Hugo FN, Hilgert JB, Padilha DMP. Association between oral health status and nutritional status in south Brazilian independent-living older people. Nutrition. 2008;24(6):546-553.
46.
Chew EY, Clemons TE, Agrón E, et al. Effect of omega-3 fatty acids, lutein/zeaxanthin, or other nutrient supplementation on cognitive function: the AREDS2 randomized clinical trial. JAMA. 2015;314(8):791-801.
47.
Hasegawa Y, Ono T, Hori K, Nokubi T. Influence of human jaw movement on cerebral blood flow. J Dent Res. 2007;86(1):64-68.
48.
Miyake S, Wada-Takahashi S, Honda H, et al. Stress and chewing affect blood flow and oxygen levels in the rat brain. Arch Oral Biol. 2012;57(11):1491-1497.
49.
Moscufo N, Wakefield DB, Meier DS, et al. Longitudinal microstructural changes of cerebral white matter and their association with mobility performance in older persons. PLoS One. 2018;13(3):e0194051.
50.
de Groot M, Verhaaren BFJ, de Boer R, et al. Changes in normal-appearing white matter precede development of white matter lesions. Stroke. 2013;44(4):1037-1042.
51.
All of Us Research Program Investigators, Denny JC, Rutter JL, et al. The “All of Us” research program. N Engl J Med. 2019;381(7):668-676.

Information & Authors

Information

Published In

Neurology®
Volume 102Number 2January 23, 2024
PubMed: 38165331

Publication History

Received: May 5, 2023
Accepted: October 3, 2023
Published online: December 20, 2023
Published in print: January 23, 2024

Permissions

Request permissions for this article.

Disclosure

The authors report no relevant disclosures. Go to Neurology.org/N for full disclosures.

Study Funding

G.J. Falcone is supported by the NIH (P30AG021342), the American Heart Association (18IDDG34280056 and 817874) and the Neurocritical Care Society Research Fellowship. A. de Havenon is supported by the NIH/National Institute of Neurological Disorders and Stroke funding (K23NS105924, R01NS130189). T.M. Gill is supported by P30AG021342.

Authors

Affiliations & Disclosures

Cyprien A. Rivier, MD, MSc https://orcid.org/0000-0002-1148-1829
From the Departments of Neurology (C.A.R., D.B.R., A.d.H., N.A.S., K.N.S., G.J.F.), Internal Medicine (T.M.G.), and Radiology (S.P.), Yale University School of Medicine; and Yale Center for Brain and Mind Health (C.A.R., A.d.H., S.P., K.N.S., G.J.F.), New Haven, CT.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
From the Departments of Neurology (C.A.R., D.B.R., A.d.H., N.A.S., K.N.S., G.J.F.), Internal Medicine (T.M.G.), and Radiology (S.P.), Yale University School of Medicine; and Yale Center for Brain and Mind Health (C.A.R., A.d.H., S.P., K.N.S., G.J.F.), New Haven, CT.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Adam de Havenon, MD, MSCI https://orcid.org/0000-0001-8178-8597
From the Departments of Neurology (C.A.R., D.B.R., A.d.H., N.A.S., K.N.S., G.J.F.), Internal Medicine (T.M.G.), and Radiology (S.P.), Yale University School of Medicine; and Yale Center for Brain and Mind Health (C.A.R., A.d.H., S.P., K.N.S., G.J.F.), New Haven, CT.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NovoNordisk
2.
Integra
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NIH, NINDS: Grants
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
Certus: Experimental intra-aortic balloon
2.
TitinKM: Shoulder rehabilitation device
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
N. Abimbola Sunmonu, MD, PhD
From the Departments of Neurology (C.A.R., D.B.R., A.d.H., N.A.S., K.N.S., G.J.F.), Internal Medicine (T.M.G.), and Radiology (S.P.), Yale University School of Medicine; and Yale Center for Brain and Mind Health (C.A.R., A.d.H., S.P., K.N.S., G.J.F.), New Haven, CT.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
From the Departments of Neurology (C.A.R., D.B.R., A.d.H., N.A.S., K.N.S., G.J.F.), Internal Medicine (T.M.G.), and Radiology (S.P.), Yale University School of Medicine; and Yale Center for Brain and Mind Health (C.A.R., A.d.H., S.P., K.N.S., G.J.F.), New Haven, CT.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NIH (P30AG021342): Grant
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Seyedmehdi Payabvash, MD https://orcid.org/0000-0003-4628-0370
From the Departments of Neurology (C.A.R., D.B.R., A.d.H., N.A.S., K.N.S., G.J.F.), Internal Medicine (T.M.G.), and Radiology (S.P.), Yale University School of Medicine; and Yale Center for Brain and Mind Health (C.A.R., A.d.H., S.P., K.N.S., G.J.F.), New Haven, CT.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NIH (K23NS118056)
Research Support, Academic Entities:
1.
Doris Duke Charitable Foundation (2020097)
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
From the Departments of Neurology (C.A.R., D.B.R., A.d.H., N.A.S., K.N.S., G.J.F.), Internal Medicine (T.M.G.), and Radiology (S.P.), Yale University School of Medicine; and Yale Center for Brain and Mind Health (C.A.R., A.d.H., S.P., K.N.S., G.J.F.), New Haven, CT.
Disclosure
Scientific Advisory Boards:
1.
CSL Behring
2.
Rhaeos
3.
Astrocyte
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Alva
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
Cerevasc
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
Grant to Yale - Hyperfine
2.
Grant to Yale - Biogen
3.
DSMB - Zoll
4.
DSMB - Sense
5.
DSMB - Phillips
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NIH: As above
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
American Heart Association: As above
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
As above - As above: As above
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
Expert testimony for As above in As above
Guido J. Falcone, MD, ScD, MPH https://orcid.org/0000-0002-6407-0302
From the Departments of Neurology (C.A.R., D.B.R., A.d.H., N.A.S., K.N.S., G.J.F.), Internal Medicine (T.M.G.), and Radiology (S.P.), Yale University School of Medicine; and Yale Center for Brain and Mind Health (C.A.R., A.d.H., S.P., K.N.S., G.J.F.), New Haven, CT.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE

Notes

Correspondence Dr. Falcone [email protected]
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Submitted and externally peer reviewed. The handling editor was Editor-in-Chief José Merino, MD, MPhil, FAAN.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Tooth Loss in Periodontitis Patients—A Risk Factor for Mild Cognitive Impairment: A Systematic Review and Meta—Analysis, Journal of Personalized Medicine, 14, 9, (953), (2024).https://doi.org/10.3390/jpm14090953
    Crossref
  2. Corrections to Preprint Server Information, Neurology, 103, 1, (2024)./doi/10.1212/WNL.0000000000209573
    Abstract
  3. Oral Health and Brain Health, Neurology, 102, 2, (2023)./doi/10.1212/WNL.0000000000208089
    Abstract
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Short Form

View Short Form

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share